Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director · Chairman and CEO · 10% owner | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2036-03-18 | Direct | 568,000 |
Reported balance
After 2026-03-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 100,000 · Balance 568,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 22, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.62 | $47.06 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,492 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 21, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.61 | $46.93 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,479 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 20, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.52 | $45.76 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,466 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 17, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.48 | $45.24 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,453 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 16, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.49 | $45.37 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,440 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 15, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.37 | $43.81 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,427 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 14, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.35 | $43.55 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,414 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 13, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.54 | $46.02 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,401 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 10, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.59 | $46.67 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,388 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 09, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.56 | $46.28 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,375 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 08, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.63 | $47.19 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,362 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 07, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.19 | $41.47 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,349 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 06, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.14 | $40.82 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,336 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 03, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.25 | $42.25 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,323 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 02, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.28 | $42.64 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,310 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| October 01, 2025 Filed Nov 3, 2025 12:56 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.31 | $43.03 |
DisclosureSEC source: 0001075050-25-000006 · wk-form4_1762174598.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,297 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 30, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.12 | $40.56 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,284 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 29, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 13 | $3.14 | $40.82 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,271 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 26, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.05 | $36.60 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,258 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 25, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.10 | $37.20 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,246 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 24, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.10 | $37.20 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,234 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 23, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.21 | $38.52 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,222 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 22, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.29 | $39.48 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,210 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 19, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.34 | $40.08 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,198 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 18, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.31 | $39.72 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,186 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 17, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.38 | $40.56 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,174 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 16, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.50 | $42.00 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,162 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 15, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.50 | $42.00 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,150 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 12, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.54 | $42.48 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,138 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 11, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.41 | $40.92 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,126 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 10, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.39 | $40.68 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,114 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 09, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.43 | $41.16 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,102 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 08, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.41 | $40.92 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,090 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 05, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.60 | $43.20 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,078 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 04, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.60 | $43.20 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,066 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 03, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.58 | $42.96 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,054 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| September 02, 2025 Filed Oct 3, 2025 20:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 12 | $3.54 | $42.48 |
DisclosureSEC source: 0001087294-25-000007 · wk-form4_1759521702.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,042 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 29, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.45 | $44.85 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,030 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 28, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.47 | $45.11 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,017 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 27, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.44 | $44.72 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,004 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 26, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.39 | $44.07 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,991 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 25, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.32 | $43.16 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,978 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 22, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.31 | $43.03 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,965 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 21, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.25 | $42.25 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,952 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 20, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 2 | $3.15 | $6.30 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,939 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 19, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.23 | $41.99 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,937 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 18, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.11 | $40.43 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,924 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 15, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $3.02 | $39.26 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,911 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 14, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $2.84 | $36.92 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,898 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
| August 13, 2025 Filed Sep 12, 2025 12:34 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 13 | $2.94 | $38.22 |
DisclosureSEC source: 0001628280-25-041985 · wk-form4_1757680454.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,699,885 F1 · shares: The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.